UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

British journal of cancer, 2006-06, Vol.94 (12), p.1765-1769

2006

Volltextzugriff (PDF)

Drug resistance in mutant FLT3-positive AML

Oncogene, 2010-09, Vol.29 (37), p.5120-5134

2010

Volltextzugriff (PDF)

Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells

Leukemia, 2015-07, Vol.29 (7), p.1555-1563

2015

Volltextzugriff (PDF)

Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis

Diagnostic and interventional imaging, 2020-02, Vol.101 (2), p.111-115

2020

Volltextzugriff (PDF)

Smac mimetics: implications for enhancement of targeted therapies in leukemia

Leukemia, 2010-12, Vol.24 (12), p.2100-2109

2010

Volltextzugriff (PDF)

Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia

Leukemia, 2016-01, Vol.30 (1), p.173-181

2016

Volltextzugriff (PDF)

Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies

Leukemia, 2015-01, Vol.29 (1), p.27-37

2015

Volltextzugriff (PDF)

Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

Leukemia, 2016-03, Vol.30 (3), p.754-757

2016

Volltextzugriff (PDF)

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib

Leukemia, 2012-05, Vol.26 (5), p.985-990

2012

Volltextzugriff (PDF)

Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors

Leukemia, 2012-10, Vol.26 (10), p.2233-2244

2012

Volltextzugriff (PDF)

Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data

Fertility and sterility, 2002-02, Vol.77 (2 Suppl 2), p.13-18

2002

Volltextzugriff (PDF)

ARG tyrosine kinase activity is inhibited by STI571

Blood, 2001-04, Vol.97 (8), p.2440-2448

2001

Volltextzugriff (PDF)

Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias

Blood, 2007-03, Vol.109 (5), p.2112-2120

2007

Volltextzugriff (PDF)

The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations

Genes & cancer, 2012-07, Vol.3 (7-8), p.503-511

2012

Volltextzugriff (PDF)

Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML

Leukemia, 2016-10, Vol.30 (10), p.2112-2116

2016

Volltextzugriff (PDF)

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/ fructose-bisphosphatase 3 for cell growth and increased metabolic activity

Leukemia, 2012-03, Vol.26 (3), p.481-489

2012

Volltextzugriff (PDF)

A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users

Human reproduction (Oxford), 2009-08, Vol.24 (8), p.1852-1861

2009

Volltextzugriff (PDF)

The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression

Leukemia, 2013-04, Vol.27 (4), p.961-964

2013

Volltextzugriff (PDF)

A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon

Human reproduction (Oxford), 2006-01, Vol.21 (1), p.295-302

2006

Volltextzugriff (PDF)

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet

Climacteric : the journal of the International Menopause Society, 2005-03, Vol.8 (1), p.83-93

2005

Volltextzugriff (PDF)

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

The New England journal of medicine, 2019-02, Vol.380 (7), p.617-628

2019

Volltextzugriff (PDF)

Development of swelling induced shear and slickensides in Vertisols

Geoderma, 2022-03, Vol.409, p.115629, Article 115629

2022

Volltextzugriff (PDF)

O100 An open-label randomised trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S121-S121

2009

Volltextzugriff (PDF)

Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CML

Leukemia, 2010-07, Vol.24 (7), p.1375-1378

2010

Volltextzugriff (PDF)

Judaism and women's health

The journal of family planning and reproductive health care, 2009-01, Vol.35 (1), p.53-55

2009

Volltextzugriff (PDF)

1 – 25 von 805

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(679)
Mit Volltextzugriff
(641)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(487)
Life Sciences & Biomedicine
(379)
Humans
(250)
Female
(164)
Biological And Medical Sciences
(163)
Adult
(101)
Medical Sciences
(100)
Physical Sciences
(100)
Male
(95)
Animals
(91)
Middle Aged
(78)
Fundamental And Applied Biological Sciences. Psychology
(63)
Environmental Sciences & Ecology
(61)
Environmental Sciences
(47)
General & Internal Medicine
(43)
Mice
(43)
Adolescent
(42)
Medicine, General & Internal
(42)
Oncology
(42)
Aged
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

Drug resistance in mutant FLT3-positive AML

Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells

Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis

Smac mimetics: implications for enhancement of targeted therapies in leukemia

Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia

Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies

Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib

Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors

Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data

ARG tyrosine kinase activity is inhibited by STI571

Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias

The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations

Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/ fructose-bisphosphatase 3 for cell growth and increased metabolic activity

A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users

The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression

A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Development of swelling induced shear and slickensides in Vertisols

O100 An open-label randomised trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears

Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CML

Judaism and women's health

Suchergebnisse filtern